We are pioneering next-generation therapies to target solid tumors, transforming scientific breakthroughs into real-world solutions for patients globally.
Read the press release →Patient safety and efficacy are our top priorities. Discover how our engineered NK cell platforms are designed to overcome resistance in the tumor microenvironment.
Learn more →We are proactively advancing our therapies from the lab to the clinic. Explore our current phases of research and upcoming milestones in oncology.
Learn more →We are committed to raising awareness and collaborating with global health authorities and industry peers to accelerate the development of life-saving medicines.
Learn more →